It has been previously reported that obesity is associated with the incidence of more aggressive, higher grade prostate cancer and greater prostate-specific antigen (PSA) failure rates following radical prostatectomy or external beam RT (EBRT) (8–14). The gene discussed is KLK3; the disease is obesity disorder.